Solara Pharma Turns Profitable in Q1

  Published 11 months ago

Solara shares jump 5% as Q1 net profit hits ₹105.2M, reversing loss; expenses drop offset revenue decline.

  • Total expenses fell 18%, helping counter a 12.2% revenue dip and return to profitability from a year-ago loss.
  • Stock eyes seventh weekly gain; over 690K shares traded, 2.2x the 30-day average, most in a month.
  • YTD performance is modest, up 2%, but momentum is building on improving financials and strong trading volume.

You might like these

Vintage Coffee Hits Record Q1 Sales

RBI Rate Cut Boosts India's NBFCs, Shares Surge

RateGain Q1 Profit Up, Margins Dip

AI Deal Worth Rs 450 Crore

Grok AI Faces Global Backlash

Mahindra EPC Irrigation Q2 Highlights

Maruti Suzuki August 2025 Sales

News that matters the most ⚡